TY - JOUR
T1 - Validation of dietary whey protein substrate challenge absorption test as an indicator of proteolysis
AU - Pierzynowska, Kateryna
AU - Pierzynowski, Stefan
AU - Zaworski, Kamil
AU - Gallotto, Robert
AU - Sathe, Meghana
AU - Freedman, Steven D.
AU - Borowitz, Drucy
N1 - Publisher Copyright:
© 2025 Pierzynowska et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2025/5
Y1 - 2025/5
N2 - Introduction Current methods to measure the effectiveness of pancreatic protease activity are inadequate. We explored the measurement of peptide-derived amino acids following ingestion of dietary whey substrate as a sensitive test of exogenous protease activity in exocrine pancreatic insufficient (EPI) pigs. Methods We studied the activity of aspergillus protease given in combination with a novel lipase and fungal amylase, as well as commercially available pancrelipase in EPI pigs. After a high-fat diet plus a standardized dietary whey substrate, blood was withdrawn at intervals and was analyzed for amine groups using a modified ninhydrin reaction. Plasma peptide-derived amino acids were calculated. Results The AUC6 peptide-derived amino acid concentration was significantly increased in response to aspergillus protease as follows: 50 mg dose (137% increase; p = 0.05), 75 mg dose (154% increase; p = 0.008) compared to no enzyme. The AUC6 for peptide-derived amino acids after aspergillus protease increased by 133% for the 50 mg dose (p = 0.0044), by 171% for the 75 mg dose (p = 0.0002), and by 113% with 600 mg pancrelipase (p < 0.0001) when compared to no enzyme. Administration of 75 mg of aspergillus protease led to significantly higher peptide-derived amino acid AUC6 and Cmax when compared to 600mg pancrelipase (p=0.0419 and 0.0103, respectively). Conclusion In EPI pigs, measurement of peptide-derived amino acids following a meal with whey substrate differentiates the activity of aspergillus protease compared to no enzyme and the 75mg dose was superior to pancrelipase. The evidence presented here in EPI pigs demonstrates that the whey substrate absorption challenge test reflects the proteolytic activity of different doses of exogenous pancreatic proteases.
AB - Introduction Current methods to measure the effectiveness of pancreatic protease activity are inadequate. We explored the measurement of peptide-derived amino acids following ingestion of dietary whey substrate as a sensitive test of exogenous protease activity in exocrine pancreatic insufficient (EPI) pigs. Methods We studied the activity of aspergillus protease given in combination with a novel lipase and fungal amylase, as well as commercially available pancrelipase in EPI pigs. After a high-fat diet plus a standardized dietary whey substrate, blood was withdrawn at intervals and was analyzed for amine groups using a modified ninhydrin reaction. Plasma peptide-derived amino acids were calculated. Results The AUC6 peptide-derived amino acid concentration was significantly increased in response to aspergillus protease as follows: 50 mg dose (137% increase; p = 0.05), 75 mg dose (154% increase; p = 0.008) compared to no enzyme. The AUC6 for peptide-derived amino acids after aspergillus protease increased by 133% for the 50 mg dose (p = 0.0044), by 171% for the 75 mg dose (p = 0.0002), and by 113% with 600 mg pancrelipase (p < 0.0001) when compared to no enzyme. Administration of 75 mg of aspergillus protease led to significantly higher peptide-derived amino acid AUC6 and Cmax when compared to 600mg pancrelipase (p=0.0419 and 0.0103, respectively). Conclusion In EPI pigs, measurement of peptide-derived amino acids following a meal with whey substrate differentiates the activity of aspergillus protease compared to no enzyme and the 75mg dose was superior to pancrelipase. The evidence presented here in EPI pigs demonstrates that the whey substrate absorption challenge test reflects the proteolytic activity of different doses of exogenous pancreatic proteases.
UR - https://www.scopus.com/pages/publications/105005708192
U2 - 10.1371/journal.pone.0323730
DO - 10.1371/journal.pone.0323730
M3 - Article
C2 - 40388429
AN - SCOPUS:105005708192
SN - 1932-6203
VL - 20
JO - PLOS ONE
JF - PLOS ONE
IS - 5 May
M1 - e0323730
ER -